J. Olesen, A. Gustavsson, and M. Svensson, The economic cost of brain disorders in Europe, Eur J Neurol, vol.19, pp.155-62, 2012.

A. I. Maas, N. Stocchetti, and R. Bullock, Moderate and severe traumatic brain injury in adults, Lancet Neurol, vol.7, pp.728-769, 2008.

K. Asehnoune, P. Seguin, and J. Allary, Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial, Lancet Respir Med, vol.2, pp.706-722, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01220644

J. M. Kahn, E. C. Caldwell, and S. Deem, Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome, Crit Care Med, vol.34, pp.196-202, 2006.

C. Meisel, J. M. Schwab, and K. Prass, Central nervous system injury-induced immune deficiency syndrome, Nat Rev Neurosci, vol.6, pp.775-86, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00088273

M. Meisner, H. Adina, and J. Schmidt, Correlation of procalcitonin and Creactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients, Crit Care Lond Engl, vol.10, p.1, 2006.

C. Martin, C. Boisson, and M. Haccoun, Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma, Crit Care Med, vol.25, pp.1813-1822, 1997.

O. Mimoz, J. F. Benoist, and A. R. Edouard, Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome, Intensive Care Med, vol.24, pp.185-193, 1998.

S. Lobo, F. Lobo, and D. P. Bota, C-reactive protein levels correlate with mortality and organ failure in critically ill patients, Chest, vol.123, pp.2043-2052, 2003.

L. Hoover, G. V. Bochicchio, and L. M. Napolitano, Systemic inflammatory response syndrome and nosocomial infection in trauma, J Trauma, vol.61, pp.310-316, 2006.

C. Meisel and A. Meisel, Suppressing immunosuppression after stroke, N Engl J Med, vol.365, pp.2134-2140, 2011.

A. Roquilly, P. J. Mahe, and P. Seguin, Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study, JAMA, vol.305, pp.1201-1210, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00741222

M. Bouras, K. Asehnoune, and A. Roquilly, Contribution of dendritic cell responses to sepsis-induced immunosuppression and to susceptibility to secondary pneumonia, Front Immunol, vol.9, p.2590, 2018.

D. Keh, T. Boehnke, and S. Weber-cartens, Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study, Am J Respir Crit Care Med, vol.167, pp.512-532, 2003.

A. Roquilly, A. Broquet, and C. Jacqueline, Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after traumahemorrhage, Crit Care Med, vol.42, pp.752-61, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01601499

N. Carney, A. M. Totten, and C. O'reilly, Guidelines for the Management of Severe Traumatic Brain Injury, Neurosurgery, vol.80, pp.6-15, 2017.

K. Asehnoune, A. Roquilly, and V. Sebille, Corticotherapy for traumatic braininjured patients--the Corti-TC trial: study protocol for a randomized controlled trial, Trials, vol.12, p.228, 2011.

, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury, Brain Trauma Foundation, vol.24, issue.1, pp.1-106, 2007.

K. Asehnoune, S. Mrozek, and P. F. Perrigault, A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project, Intensive Care Med, vol.43, pp.957-70, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01775139

R. Cinotti, M. Bouras, and A. Roquilly, Management and weaning from mechanical ventilation in neurologic patients, Ann Transl Med, vol.6, p.381, 2018.

A. C. Kalil, M. L. Metersky, and M. Klompas, Management of Adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the, Clin Infect Dis, vol.63, pp.61-111, 2016.

O. Engel, L. Akyüz, C. Da, and A. C. Goncalves, Cholinergic pathway suppresses pulmonary innate immunity facilitating pneumonia after stroke, Stroke, vol.46, pp.3232-3272, 2015.

H. Wang, M. Yu, and M. Ochani, Nicotinic acetylcholine receptor ?7 subunit is an essential regulator of inflammation, Nature, vol.421, pp.384-392, 2003.

E. Boonen, H. Vervenne, and P. Meersseman, Reduced cortisol metabolism during critical illness, N Engl J Med, vol.368, pp.1477-88, 2013.

P. E. Marik, S. M. Pastores, and D. Annane, Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine, Crit Care Med, vol.36, pp.1937-1986, 2008.

N. E. Spruijt, T. Visser, and L. P. Leenen, A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients, Crit Care Lond Engl, vol.14, p.150, 2010.

A. Roquilly, H. Mcwilliam, and C. Jacqueline, Local modulation of antigenpresenting cell development after resolution of pneumonia induces longterm susceptibility to secondary infections, Immunity, vol.47, pp.135-182, 2017.

A. Torres, O. Sibila, and M. Ferrer, Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial, JAMA, vol.313, p.677, 2015.

S. Hoen, K. Asehnoune, and S. Brailly-tabard, Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock, Anesthesiology, vol.97, pp.807-820, 2002.

D. Annane, S. M. Pastores, and B. Rochwerg, Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017, Intensive Care Med, vol.43, pp.1751-63, 2017.

G. Mastorakos, G. P. Chrousos, and J. S. Weber, Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans, J Clin Endocrinol Metab, vol.77, pp.1690-1694, 1993.

P. Kalabalikis, K. Papazoglou, and D. Gouriotis, Correlation between serum IL-6 and CRP levels and severity of head injury in children, Intensive Care Med, vol.25, pp.288-92, 1999.

I. P. Aisiku, J. Doshi, and P. , Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury, Crit Care, vol.20, p.288, 2016.

S. Fernández-serrano, J. Dorca, and C. Garcia-vidal, Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial, Crit Care, vol.15, p.96, 2011.

N. Fujio, S. Masuoka, and K. Shikano, Apparent hypothalamic-pituitaryadrenal axis suppression via reduction of interleukin-6 by glucocorticoid therapy in systemic autoimmune diseases, PLoS One, vol.11, p.167854, 2016.

C. Woiciechowsky, B. Schöning, and J. Cobanov, Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients, J Trauma, vol.52, pp.339-384, 2002.

J. Huang, J. Guo, and H. Li, Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: a systematic review and meta-analysis, Medicine (Baltimore), vol.98, p.14636, 2019.

N. Fabregas, A. Torres, and M. El-ebiary, Histopathologic and microbiologic aspects of ventilator-associated pneumonia, Anesthesiol J Am Soc Anesthesiol, vol.84, pp.760-71, 1996.

A. Alcón, N. Fàbregas, and A. Torres, Pathophysiology of pneumonia, Clin Chest Med, vol.26, pp.39-46, 2005.

L. A. Van-vught, B. P. Scicluna, and M. A. Wiewel, Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically ill patients, Am J Respir Crit Care Med, vol.194, pp.1366-74, 2016.

. Caulfield, . Fernandez, and . Sousa, Regulation of major histocompatibility complex class II antigens on human alveolar macrophages by granulocytemacrophage colony-stimulating factor in the presence of glucocorticoids, Immunology, vol.98, pp.104-114, 1999.

A. M. Jamieson, S. Yu, and C. H. Annicelli, Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection, Cell Host Microbe, vol.7, pp.103-117, 2010.

I. Roberts, D. Yates, and P. Sandercock, Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial, Lancet Lond Engl, vol.364, pp.1321-1329, 2004.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations